Please assess the completion status of the following clinical trial:

Trial Title: Transfer and Ultrafiltration In Peritoneal Dialysis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients hospitalized in the Nephrology department of the Besançon University Hospital~* Patients treated by continuous ambulatory peritoneal dialysis or ambulatory peritoneal dialysis for at least 6 months~* Absence of hospitalization caused by an infection in the month prior to inclusion~* Patients with a ratio (D / P) of the concentration of creatinine in the blood and dialysate between 0.5 and 0.8 on a checkup of less than 1 year.~* No contraindication to the use of hypertonic bag~* Signature of informed consent for participation indicating that the subject has understood the purpose and procedures required by the study and agrees to participate in the study and comply with the requirements and limitations inherent in this study~* Affiliation to a French social security system or beneficiary~Exclusion Criteria:~* Legal incapacity or limited legal capacity~* Patients unlikely to cooperate in the study and/or low cooperation anticipated by the investigator~* Patients without health insurance~* Pregnant women~* Patient being in the exclusion period from another study or planned by the national register of volunteers~* Hospitalization caused by an infection in the month prior to inclusion~* Patients with a peritoneal dialysis catheter dysfunction

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- conventional scheme followed by alternate schem (Type: EXPERIMENTAL): The first day of the study, patients receive an adapted conventional peritoneal dialysis scheme: 2 cycles of ultrafiltration (stasis: 35 mn ; volume: 650cc/m²) and 2 cycles of purification (stasis: 110 mn ; volume 1200cc/m²).~The second day, patients receive an adapted and alternate scheme: 1 cycle of ultrafiltration (stasis: 35 mn ; volume: 650cc/m²) and 1 cycle of purification (stasis: 110 mn ; volume 1200cc/m²), the two cycles being repeated once.
- alternate scheme followed by conventional scheme (Type: EXPERIMENTAL): The first day of the study, patients receive an adapted and alternate peritoneal dialysis scheme: 1 cycle of ultrafiltration (stasis: 35 mn ; volume: 650cc/m²) and 1 cycle of purification (stasis: 110 mn ; volume 1200cc/m²), the two cycles being repeated once.~The second day, patients receive an adapted conventional scheme: 2 cycles of ultrafiltration (stasis: 35 mn ; volume: 650cc/m²) and 2 cycles of purification (stasis: 110 mn ; volume 1200cc/m²).

Based on this trial design, predict the completion outcome and termination type (if applicable).